StockDuty ← Dashboard Nov 05, 2026 09:55 PM ET
SignalCorporate

10x Genomics GAAP EPS of -$0.15 beats by $0.11, revenue of $150.7M beats by $2.85M

10x Genomics beat EPS and revenue estimates, indicating stronger-than-expected financial performance.

What changed
10x Genomics beat EPS and revenue estimates, indicating stronger-than-expected financial performance.
Why it matters
10x Genomics beat EPS and revenue estimates, indicating stronger-than-expected financial performance. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →